The Promise of Regenerative Medicine & Advanced Therapies in Oncology

This in-depth session will examine the progress of regenerative medicine and advanced therapies specifically as the field relates to the area of oncology. The panel's expert speakers will discuss a number of key hurdles on the path to commercialization including reimbursement and market access and what progress can be expected in the sector in the coming year.

Speakers:
Joshua Schimmer, Managing Director & Senior Research Analyst, Piper Jaffray (moderator)
Jeffrey Abbey, President & CEO, Argos Therapeutics
Usman Azam, Global Head, Cell & Gene Therapies Unit, Novartis
André Choulika, Chairman & CEO, Cellectis
Gregg Sando, Founder & CEO, Cell Medica